Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
2 Under-the-Radar Biotech Stocks to Buy in 2022
10:53am, Friday, 12'th Aug 2022
It's been a wild 12 months for these companies.
Axsome (AXSM) Q2 Loss Narrower Than Expected, Revenues Miss
12:02pm, Wednesday, 10'th Aug 2022
Axsome (AXSM) reports narrower-than-expected loss for the second quarter of 2022. The company records its first sales of the sleep drug, Sunosi, which it acquired from Jazz.
Why Axsome Therapeutics Topped the Market Today
07:16pm, Tuesday, 09'th Aug 2022
The company records nearly $9 million in quarterly sales from its recently acquired drug.
Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q2 2022 Results - Earnings Call Transcript
02:58pm, Tuesday, 09'th Aug 2022
Axsome Therapeutics, Inc. (NASDAQ:AXSM ) Q2 2022 Earnings Conference Call August 9, 2022 8:00 AM ET Company Participants Mark Jacobson - Chief Operating Officer Herriot Tabuteau - Founder, Chairman, C
Axsome Therapeutics (AXSM) Reports Q2 Loss, Lags Revenue Estimates
09:47am, Tuesday, 09'th Aug 2022
Axsome (AXSM) delivered earnings and revenue surprises of 10.92% and 8.01%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Axsome Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
07:00am, Thursday, 28'th Jul 2022
Axsome to host conference call and webcast on Tuesday, August 9, 2022 at 8:00 AM Eastern Time
Axsome: Breaking Bearish Trend
09:59am, Tuesday, 26'th Jul 2022
Axsome Therapeutics encountered some regulatory setbacks relating to its lead medicine AXS05 for major depressive disorder. Axsome recently posted more positive data on AXS05 for such depression. More
3 Beaten-Down Stocks That Could Soar in the Second Half of 2022
05:58am, Saturday, 23'rd Jul 2022
Each of these stocks is ready for a rebound.
What's Winning in 2022? 3 Stocks That Are Doing Fine
06:00am, Saturday, 16'th Jul 2022
Immunocore, Axsome Therapeutics, and Takeda are significantly outperforming the market this year.
Got $500? 3 Absurdly Cheap Healthcare Stocks That Are Set to Skyrocket
04:45pm, Friday, 01'st Jul 2022
Here's why these Fool.com contributors are bullish on Adaptimmune Therapeutics, G1 Therapeutics, and Axsome Therapeutics.
Axsome: One Step At A Time
04:08pm, Friday, 01'st Jul 2022
AXS-05 labeling discussions with the FDA imply imminent approval. Next 12-18 months will see Axsome transform into a significant commercial neuroscience biotech.
Axsome (AXSM) Hurt by Regulatory Setbacks: Will It Recover?
11:44am, Thursday, 30'th Jun 2022
Axsome's (AXSM) extension of the review period for AXS-05 NDA and CRL for AXS-07 NDA hurt prospects. However, recent positive updates on AXS-05 are driving positive sentiments.
2 Biotechs That Recently Soared -- Are They Buys?
10:23am, Thursday, 30'th Jun 2022
Let's consider the risk-reward profile of these companies before jumping on the bandwagon.
Axsome (AXSM) Surges Following FDA Label Proposal for AXS-05
11:35am, Tuesday, 28'th Jun 2022
Axsome (AXSM) receives proposed labeling from the FDA for its under-review depression drug candidate, AXS-05, implying a potential approval soon. Shares surge more than 50%.
Cheap Stocks To Buy Today? 3 Health Care Stocks For Your Watchlist
12:30pm, Monday, 27'th Jun 2022
While individuals are fearing another pandemic, could health care stocks be a great addition to your watchlist?
